Open AccessDeterminants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin Therapy
Author(s) -
Samia Mora,
Nanette K. Wenger,
David A. DeMicco,
Andrei Breazna,
S. Matthijs Boekholdt,
Benoît J. Arsenault,
Prakash Deedwania,
John J.P. Kastelein,
David D. Waters
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.088591
Subject(s) - medicine , residual risk , statin , secondary prevention , primary prevention , cardiology , disease
Cardiovascular events occur among statin-treated patients, albeit at lower rates. Risk factors for this "residual risk" have not been studied comprehensively. We aimed to identify determinants of this risk above and beyond lipid-related risk factors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom